Berkeley Capital Partners »

Immunitybio shares owned by Berkeley Capital Partners

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Berkeley Capital Partners from 13F filings

Historical chart of Berkeley Capital Partners investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Berkeley Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Berkeley Capital Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $25k 10k 2.46
2025-06-30 $26k 10k 2.64

More positions owned by Berkeley Capital Partners

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Whitehall Fds High Div Yld (VYM)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Scottsdale Fds Lg-term Cor Bd (VCLT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Vaneck Etf Trust Gold Miners Etf (GDX)
Coastalsouth Bancshares Com New (COSO)
Spdr Series Trust Portfolio S&p600 (SPSM)
Spdr Series Trust Portfolio S&p400 (SPMD)
Microsoft Corporation (MSFT)
Ishares Tr U.s. Tech Etf (IYW)
Vanguard World Industrial Etf (VIS)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)

View all positions for Berkeley Capital Partners

Top funds holding Immunitybio

Vanguard Group
BlackRock
Jane Street
State Street Corporation
Geode Capital Management
Heights Capital Management
Woodline Partners
Susquehanna International
AlphaCore Capital
Morgan Stanley
Two Sigma Investments
Tang Capital Management
Charles Schwab Investment Management
Citadel Advisors
Northern Trust

View all funds holding Immunitybio